TuisSFOSF • OTCMKTS
add
Shanghai Fosun Pharmaceutical (Group) Ord Shs H
Vorige sluiting
$1,70
Jaarwisseling
$1,50 - $2,24
Markkapitalisasie
60,97Â mjd HKD
Gemiddelde volume
35,00
P/V-verhouding
-
Dividend-opbrengs
-
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (CNY) | Sep. 2024info | J/J-verandering |
|---|---|---|
Inkomste | 10,45Â mjd | 12,30% |
Bedryfskoste | 4,11Â mjd | -4,30% |
Netto inkomste | 785,84Â m | 55,43% |
Netto winsgrens | 7,52 | 38,49% |
Wins per aandeel | — | — |
EBITDA | 1,60Â mjd | 229,39% |
Effektiewe belastingkoers | 15,05% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (CNY) | Sep. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 15,63Â mjd | -1,12% |
Totale bates | 115,26Â mjd | 4,06% |
Totale aanspreeklikheid | 56,07Â mjd | 2,35% |
Totale ekwiteit | 59,19 mjd | — |
Uitstaande aandele | 2,66 mjd | — |
Prys om te bespreek | 0,10 | — |
Opbrengs op bates | 2,03% | — |
Opbrengs op kapitaal | 2,49% | — |
Kontantvloei
Netto kontantverandering
| (CNY) | Sep. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | 785,84Â m | 55,43% |
Kontant van bedrywe | 1,08Â mjd | 65,68% |
Kontant van beleggings | 210,24Â m | 122,80% |
Kontant van finansiering | -1,59Â mjd | 11,34% |
Netto kontantverandering | -389,75Â m | 80,29% |
Beskikbare kontantvloei | -2,97Â mjd | 27,05% |
Meer oor
Shanghai Fosun Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company. It is mostly owned by Fosun International.
As of 2018, the A shares of the company is a constituent of SSE 180 Index as well as its sub-index SSE MidCap Index. The company was ranked 1,840th in 2020 edition of the Forbes Global 2000, a list of top listed companies of the world. Wikipedia
Gestig
1994
Webwerf
Werknemers
39Â 309
